Chemed CHE Segment Vitas — Income Tax Expense Benefit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's segment vitas — income tax expense benefit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemed's segment vitas — income tax expense benefit?
- Chemed (CHE) reported segment vitas — income tax expense benefit of $16.53M in Q1 2026.
- How has Chemed's segment vitas — income tax expense benefit changed year-over-year?
- Chemed's segment vitas — income tax expense benefit decreased by 8.4% year-over-year, from $18.04M to $16.53M.
- What is the long-term trend for Chemed's segment vitas — income tax expense benefit?
- Over 4 years (2021 to 2025), Chemed's segment vitas — income tax expense benefit has grown at a 5.7% compound annual growth rate (CAGR), from $52.43M to $65.52M.
- What does segment vitas — income tax expense benefit mean?
- This metric reflects the total tax liability or benefit recognized by the segment based on its taxable income for the period. It is essential for understanding the segment's effective tax rate and the impact of tax regulations on its net financial performance.